Disclaimer: Cannabis Investor News is for informational purposes only—not investment advice. We are not registered with the SEC, FINRA, or any regulatory body. Data may be delayed or inaccurate. Cannabis securities carry significant risk; you could lose your entire investment. Always consult a licensed financial advisor and verify all information independently before making any investment decision.
Cannabis Capital Markets — Financing Deals and Insider Transactions
Track cannabis industry financing deals, equity raises, debt issuances, convertible notes, and insider transactions on CIN's Capital Markets dashboard. Our coverage includes all publicly disclosed financing events from SEC filings, SEDAR disclosures, press releases, and regulatory filings across U.S. and Canadian cannabis companies.
The deals dashboard displays trailing 12-month deal flow with sortable columns for company name, deal type, amount raised, date filed, and financing terms. Deal types tracked include common equity offerings, bought deals, at-the-market (ATM) programs, convertible debentures, credit facilities, term loans, private placements, and restructuring transactions. Cannabis capital markets activity serves as a leading indicator for sector health. Accelerating deal volume with favorable terms signals management confidence in growth prospects, while elevated restructuring activity and distressed financing indicate sector stress. CIN's Sector Stress Index quantifies the ratio of restructuring events to total financing activity, providing an early warning system for deteriorating cannabis sector fundamentals.
Insider transactions — including open-market purchases and sales by officers, directors, and beneficial owners — are tracked alongside institutional financing to provide a complete picture of cannabis capital flows. Insider buying clusters have historically preceded positive sector catalysts in the cannabis industry.